These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

337 related items for PubMed ID: 23440963

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction.
    Cole RN, Reddel SW, Gervásio OL, Phillips WD.
    Ann Neurol; 2008 Jun; 63(6):782-9. PubMed ID: 18384168
    [Abstract] [Full Text] [Related]

  • 3. The mouse passive-transfer model of MuSK myasthenia gravis: disrupted MuSK signaling causes synapse failure.
    Ghazanfari N, Trajanovska S, Morsch M, Liang SX, Reddel SW, Phillips WD.
    Ann N Y Acad Sci; 2018 Jan; 1412(1):54-61. PubMed ID: 29125188
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Efgartigimod improves muscle weakness in a mouse model for muscle-specific kinase myasthenia gravis.
    Huijbers MG, Plomp JJ, van Es IE, Fillié-Grijpma YE, Kamar-Al Majidi S, Ulrichts P, de Haard H, Hofman E, van der Maarel SM, Verschuuren JJ.
    Exp Neurol; 2019 Jul; 317():133-143. PubMed ID: 30851266
    [Abstract] [Full Text] [Related]

  • 7. 3,4-Diaminopyridine improves neuromuscular transmission in a MuSK antibody-induced mouse model of myasthenia gravis.
    Mori S, Kishi M, Kubo S, Akiyoshi T, Yamada S, Miyazaki T, Konishi T, Maruyama N, Shigemoto K.
    J Neuroimmunol; 2012 Apr; 245(1-2):75-8. PubMed ID: 22409941
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effects of the ß2-adrenoceptor agonist, albuterol, in a mouse model of anti-MuSK myasthenia gravis.
    Ghazanfari N, Morsch M, Tse N, Reddel SW, Phillips WD.
    PLoS One; 2014 Apr; 9(2):e87840. PubMed ID: 24505322
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice.
    Klooster R, Plomp JJ, Huijbers MG, Niks EH, Straasheijm KR, Detmers FJ, Hermans PW, Sleijpen K, Verrips A, Losen M, Martinez-Martinez P, De Baets MH, van der Maarel SM, Verschuuren JJ.
    Brain; 2012 Apr; 135(Pt 4):1081-101. PubMed ID: 22396395
    [Abstract] [Full Text] [Related]

  • 14. Guidelines for pre-clinical animal and cellular models of MuSK-myasthenia gravis.
    Phillips WD, Christadoss P, Losen M, Punga AR, Shigemoto K, Verschuuren J, Vincent A.
    Exp Neurol; 2015 Aug; 270():29-40. PubMed ID: 25542979
    [Abstract] [Full Text] [Related]

  • 15. Anti-LRP4 autoantibodies in AChR- and MuSK-antibody-negative myasthenia gravis.
    Pevzner A, Schoser B, Peters K, Cosma NC, Karakatsani A, Schalke B, Melms A, Kröger S.
    J Neurol; 2012 Mar; 259(3):427-35. PubMed ID: 21814823
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Specific binding of collagen Q to the neuromuscular junction is exploited to cure congenital myasthenia and to explore bases of myasthenia gravis.
    Ohno K, Ito M, Kawakami Y, Krejci E, Engel AG.
    Chem Biol Interact; 2013 Mar 25; 203(1):335-40. PubMed ID: 22981737
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. MuSK induced experimental autoimmune myasthenia gravis does not require IgG1 antibody to MuSK.
    Küçükerden M, Huda R, Tüzün E, Yılmaz A, Skriapa L, Trakas N, Strait RT, Finkelman FD, Kabadayı S, Zisimopoulou P, Tzartos S, Christadoss P.
    J Neuroimmunol; 2016 Jun 15; 295-296():84-92. PubMed ID: 27235354
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.